Current Non-HSCT Treatments for SCD View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2017-07-12

AUTHORS

Claire L. Anderson , Deepika S. Darbari

ABSTRACT

Sickle cell disease (SCD) is associated with many acute and chronic complications which require management with pharmacologic agents. Advances in health care and public policies have successfully reduced the mortality in children with SCD and has led to its evolution into a chronic disease in adults living with SCD. While management of SCD remains largely symptomatic with only one FDA-approved pharmacologic disease-modifying agent hydroxyurea, improved understanding of complex mechanisms underlying the pathophysiology of SCD is paving way for new therapies. In this chapter we review current disease-modifying therapies and supportive care for patients with SCD and briefly discuss pharmacologic agents currently under investigation. More... »

PAGES

65-86

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-319-62328-3_3

DOI

http://dx.doi.org/10.1007/978-3-319-62328-3_3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1091881261


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Children\u2019s National Medical Center, 111 Michigan Avenue, NW, 20010-2916, Washington, DC, USA", 
          "id": "http://www.grid.ac/institutes/grid.239560.b", 
          "name": [
            "Department of Pediatrics, Children\u2019s National Medical Center, 111 Michigan Avenue, NW, 20010-2916, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Anderson", 
        "givenName": "Claire L.", 
        "id": "sg:person.011573006121.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011573006121.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Hematology, Center for Cancer and Blood Disorders, Children\u2019s National Medical Center, George Washington University School of Medicine and Health Sciences, 20010-2916, Washington, DC, USA", 
          "id": "http://www.grid.ac/institutes/grid.253615.6", 
          "name": [
            "Division of Hematology, Center for Cancer and Blood Disorders, Children\u2019s National Medical Center, George Washington University School of Medicine and Health Sciences, 20010-2916, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Darbari", 
        "givenName": "Deepika S.", 
        "id": "sg:person.01146660147.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146660147.39"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2017-07-12", 
    "datePublishedReg": "2017-07-12", 
    "description": "Sickle cell disease (SCD) is associated with many acute and chronic complications which require management with pharmacologic agents. Advances in health care and public policies have successfully reduced the mortality in children with SCD and has led to its evolution into a chronic disease in adults living with SCD. While management of SCD remains largely symptomatic with only one FDA-approved pharmacologic disease-modifying agent hydroxyurea, improved understanding of complex mechanisms underlying the pathophysiology of SCD is paving way for new therapies. In this chapter we review current disease-modifying therapies and supportive care for patients with SCD and briefly discuss pharmacologic agents currently under investigation.", 
    "editor": [
      {
        "familyName": "Meier", 
        "givenName": "Emily Riehm", 
        "type": "Person"
      }, 
      {
        "familyName": "Abraham", 
        "givenName": "Allistair", 
        "type": "Person"
      }, 
      {
        "familyName": "Fasano", 
        "givenName": "Ross M.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-319-62328-3_3", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-319-62327-6", 
        "978-3-319-62328-3"
      ], 
      "name": "Sickle Cell Disease and Hematopoietic Stem Cell Transplantation", 
      "type": "Book"
    }, 
    "keywords": [
      "sickle cell disease", 
      "pharmacologic agents", 
      "current disease-modifying therapies", 
      "pathophysiology of SCD", 
      "disease-modifying therapies", 
      "management of SCD", 
      "chronic complications", 
      "supportive care", 
      "chronic diseases", 
      "cell disease", 
      "new therapies", 
      "health care", 
      "therapy", 
      "disease", 
      "care", 
      "agent hydroxyurea", 
      "complications", 
      "patients", 
      "pathophysiology", 
      "agents", 
      "mortality", 
      "complex mechanisms", 
      "management", 
      "adults", 
      "FDA", 
      "treatment", 
      "children", 
      "hydroxyurea", 
      "mechanism", 
      "advances", 
      "investigation", 
      "understanding", 
      "briefly", 
      "chapter", 
      "public policy", 
      "policy", 
      "way", 
      "evolution", 
      "pharmacologic disease-modifying agent hydroxyurea", 
      "disease-modifying agent hydroxyurea", 
      "Current Non-HSCT Treatments", 
      "Non-HSCT Treatments"
    ], 
    "name": "Current Non-HSCT Treatments for SCD", 
    "pagination": "65-86", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1091881261"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-319-62328-3_3"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-319-62328-3_3", 
      "https://app.dimensions.ai/details/publication/pub.1091881261"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2021-11-01T19:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/chapter/chapter_437.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-319-62328-3_3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-62328-3_3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-62328-3_3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-62328-3_3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-62328-3_3'


 

This table displays all metadata directly associated to this object as RDF triples.

122 TRIPLES      23 PREDICATES      66 URIs      59 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-319-62328-3_3 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author Nec0bf12309334919bcd1f428824585af
4 schema:datePublished 2017-07-12
5 schema:datePublishedReg 2017-07-12
6 schema:description Sickle cell disease (SCD) is associated with many acute and chronic complications which require management with pharmacologic agents. Advances in health care and public policies have successfully reduced the mortality in children with SCD and has led to its evolution into a chronic disease in adults living with SCD. While management of SCD remains largely symptomatic with only one FDA-approved pharmacologic disease-modifying agent hydroxyurea, improved understanding of complex mechanisms underlying the pathophysiology of SCD is paving way for new therapies. In this chapter we review current disease-modifying therapies and supportive care for patients with SCD and briefly discuss pharmacologic agents currently under investigation.
7 schema:editor N5d4442a45ae94dff9d199b99e8d6e087
8 schema:genre chapter
9 schema:inLanguage en
10 schema:isAccessibleForFree false
11 schema:isPartOf N19b7eab789ff4026b1309c881b30a4e0
12 schema:keywords Current Non-HSCT Treatments
13 FDA
14 Non-HSCT Treatments
15 adults
16 advances
17 agent hydroxyurea
18 agents
19 briefly
20 care
21 cell disease
22 chapter
23 children
24 chronic complications
25 chronic diseases
26 complex mechanisms
27 complications
28 current disease-modifying therapies
29 disease
30 disease-modifying agent hydroxyurea
31 disease-modifying therapies
32 evolution
33 health care
34 hydroxyurea
35 investigation
36 management
37 management of SCD
38 mechanism
39 mortality
40 new therapies
41 pathophysiology
42 pathophysiology of SCD
43 patients
44 pharmacologic agents
45 pharmacologic disease-modifying agent hydroxyurea
46 policy
47 public policy
48 sickle cell disease
49 supportive care
50 therapy
51 treatment
52 understanding
53 way
54 schema:name Current Non-HSCT Treatments for SCD
55 schema:pagination 65-86
56 schema:productId N5706be8dd1a74f818e51e1e8e6c22327
57 Nff75d0c0b68e4d2292b70f4cd78964e5
58 schema:publisher Nc3b397abf06c43d796f450a689eadc8a
59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091881261
60 https://doi.org/10.1007/978-3-319-62328-3_3
61 schema:sdDatePublished 2021-11-01T19:01
62 schema:sdLicense https://scigraph.springernature.com/explorer/license/
63 schema:sdPublisher N7cf62caddc224c7fbb54360e5946a369
64 schema:url https://doi.org/10.1007/978-3-319-62328-3_3
65 sgo:license sg:explorer/license/
66 sgo:sdDataset chapters
67 rdf:type schema:Chapter
68 N19b7eab789ff4026b1309c881b30a4e0 schema:isbn 978-3-319-62327-6
69 978-3-319-62328-3
70 schema:name Sickle Cell Disease and Hematopoietic Stem Cell Transplantation
71 rdf:type schema:Book
72 N4dd0d3af0434482f9da263cf40847357 rdf:first sg:person.01146660147.39
73 rdf:rest rdf:nil
74 N5706be8dd1a74f818e51e1e8e6c22327 schema:name dimensions_id
75 schema:value pub.1091881261
76 rdf:type schema:PropertyValue
77 N5d4442a45ae94dff9d199b99e8d6e087 rdf:first Nae10c2f3f0c34838ad521be876825abe
78 rdf:rest N7dad402013744aefa54f41ae8ff084a1
79 N7cf62caddc224c7fbb54360e5946a369 schema:name Springer Nature - SN SciGraph project
80 rdf:type schema:Organization
81 N7dad402013744aefa54f41ae8ff084a1 rdf:first N8fb13051fd15477d80a300f335ce8ebb
82 rdf:rest Ncf507e497c524014a730cd0c0a50258a
83 N8fb13051fd15477d80a300f335ce8ebb schema:familyName Abraham
84 schema:givenName Allistair
85 rdf:type schema:Person
86 N9fb06d71ff1c4c01a7e5bf2c28850b61 schema:familyName Fasano
87 schema:givenName Ross M.
88 rdf:type schema:Person
89 Nae10c2f3f0c34838ad521be876825abe schema:familyName Meier
90 schema:givenName Emily Riehm
91 rdf:type schema:Person
92 Nc3b397abf06c43d796f450a689eadc8a schema:name Springer Nature
93 rdf:type schema:Organisation
94 Ncf507e497c524014a730cd0c0a50258a rdf:first N9fb06d71ff1c4c01a7e5bf2c28850b61
95 rdf:rest rdf:nil
96 Nec0bf12309334919bcd1f428824585af rdf:first sg:person.011573006121.99
97 rdf:rest N4dd0d3af0434482f9da263cf40847357
98 Nff75d0c0b68e4d2292b70f4cd78964e5 schema:name doi
99 schema:value 10.1007/978-3-319-62328-3_3
100 rdf:type schema:PropertyValue
101 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
102 schema:name Medical and Health Sciences
103 rdf:type schema:DefinedTerm
104 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
105 schema:name Cardiorespiratory Medicine and Haematology
106 rdf:type schema:DefinedTerm
107 sg:person.01146660147.39 schema:affiliation grid-institutes:grid.253615.6
108 schema:familyName Darbari
109 schema:givenName Deepika S.
110 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146660147.39
111 rdf:type schema:Person
112 sg:person.011573006121.99 schema:affiliation grid-institutes:grid.239560.b
113 schema:familyName Anderson
114 schema:givenName Claire L.
115 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011573006121.99
116 rdf:type schema:Person
117 grid-institutes:grid.239560.b schema:alternateName Department of Pediatrics, Children’s National Medical Center, 111 Michigan Avenue, NW, 20010-2916, Washington, DC, USA
118 schema:name Department of Pediatrics, Children’s National Medical Center, 111 Michigan Avenue, NW, 20010-2916, Washington, DC, USA
119 rdf:type schema:Organization
120 grid-institutes:grid.253615.6 schema:alternateName Division of Hematology, Center for Cancer and Blood Disorders, Children’s National Medical Center, George Washington University School of Medicine and Health Sciences, 20010-2916, Washington, DC, USA
121 schema:name Division of Hematology, Center for Cancer and Blood Disorders, Children’s National Medical Center, George Washington University School of Medicine and Health Sciences, 20010-2916, Washington, DC, USA
122 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...